Tau protein in Alzheimer’s disease (AD) and tauopathies becomes insoluble due to hyperphosphorylation, conformational alterations, and aggregation. To analyze insoluble tau and pathological tau species, this study employs a methodology that utilizes wild-type and transgenic tau mice (P310S Tau) tissue extraction using 1% Sarkosyl or N-Lauroylsarcosine sodium salt and the radio immunoprecipitation assay (RIPA) buffer. However, the commonly used methods to study the insoluble tau fraction using detergents like Sarkosyl and RIPA require a large amount of homogenate, which can pose challenges when dealing with small tissue samples. Additionally, the study employs immunohistochemistry to visualize and quantify the pathological tau species in the brain tissue of transgenic mice, aiming to identify and analyze pathological tau species such as hyperphosphorylated tau to further our understanding of tauopathies such as Alzheimer’s disease.
CITATION STYLE
Singh, A. K., Selvarasu, K., & Durairajan, S. S. K. (2024). Isolation and Detection of Pathological Tau Species in a Tauopathy Mouse Model. In Methods in Molecular Biology (Vol. 2761, pp. 317–328). Humana Press Inc. https://doi.org/10.1007/978-1-0716-3662-6_23
Mendeley helps you to discover research relevant for your work.